Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibility

20 Sept 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Genetic factors in colorectal cancer
Share to Genomics and Rare Diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 30254378
DOI: 10.1038/s41436-018-0277-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population-based genetic testing of asymptomatic women for breast and ovarian cancer susceptibilityPMID 30254378Read ↗

Testing for inherited susceptibility to breast and ovarian cancer.Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.Semantic proximity Read ↗

Clinical implications of genetic testing for inherited breast and ovarian cancer risk.Semantic proximity Read ↗

Germline Genetic Testing for Hereditary Breast and Ovarian Cancer: Current Concepts in Risk Evaluation.Semantic proximity Read ↗

Genetic susceptibility to breast and ovarian cancer: risk assessment, genetic counseling, and management issues.Semantic proximity Read ↗

Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.Semantic proximity Read ↗

Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.Semantic proximity Read ↗

Genetic risk assessment for breast and ovarian cancer.Semantic proximity Read ↗

Panel testing for inherited susceptibility to breast, ovarian, and colorectal cancer.Semantic proximity Read ↗

Population‐based genetic testing for cancer susceptibility genes: quo vadis?Semantic proximity Read ↗

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?Semantic proximity Read ↗

Testing for Inherited Susceptibility to Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.